Neuromuscular Blockade Clinical Trials

17 recruiting

Neuromuscular Blockade Trials at a Glance

23 actively recruiting trials for neuromuscular blockade are listed on ClinicalTrialsFinder across 6 cities in 14 countries. The largest study group is Not Applicable with 8 trials, with the heaviest enrollment activity in Shanghai, Copenhagen, and Anqing. Lead sponsors running neuromuscular blockade studies include Jiangsu HengRui Medicine Co., Ltd., Matias Vested, and Seoul National University Hospital.

Browse neuromuscular blockade trials by phase

Treatments under study

About Neuromuscular Blockade Clinical Trials

Looking for clinical trials for Neuromuscular Blockade? There are currently 17 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Neuromuscular Blockade trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Neuromuscular Blockade clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 23 trials

Recruiting
Phase 2

Safety and Efficacy of HRS-9190 Compared to Cisatracurium for Continuous Intravenous Infusion in Adults

Neuromuscular Blockade
Jiangsu HengRui Medicine Co., Ltd.60 enrolled2 locationsNCT07446309
Recruiting

Comparison of an Acceleromyography- and Electromyography-based Neuromuscular Monitor With TOF-Watch ® Monitor

Neuromuscular Blockade
Huazhong University of Science and Technology100 enrolled2 locationsNCT05632107
Recruiting
Phase 2

Safety and Efficacy of HRS-9190 Compared to Rocuronium for Bolus Maintenance in Adults

Neuromuscular Blockade
Jiangsu HengRui Medicine Co., Ltd.90 enrolled2 locationsNCT07404579
Recruiting

Sarcopenia and Neuromuscular Block in Gastrointestinal Cancer Surgery

SarcopeniaGastrointestinal CancerNeuromuscular Blockade
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital100 enrolled1 locationNCT07003061
Recruiting

Comparison of the Performances of the cTOFR and the mTOFR During Reversal of Deep Neuromuscular Blockade With Sugammadex

Neuromuscular Blockade
Ankara University199 enrolled1 locationNCT06220136
Recruiting

Median Versus Ulnar Nerve Quantitative Electromyography Neuromuscular Blockade Monitoring Comparison

Neuromuscular Blockade
Loma Linda University32 enrolled1 locationNCT06553131
Recruiting
Not Applicable

The TOF3D Mechanomyograph. Evaluation of a New Device for Assessment of the Neuromuscular Block.

MechanomyographyNeuromuscular Blockade Monitoring
Klinikum Hersfeld-Rotenburg50 enrolled1 locationNCT07371377
Recruiting
Not Applicable

Partial Neuromuscular Blockade in Acute Hypoxemic Respiratory Failure

Mechanical VentilationRespiratory InsufficiencyNeuromuscular Blockade
University Health Network, Toronto23 enrolled1 locationNCT04524585
Recruiting
Phase 1

A Single Ascending Dose of HRS-2162 in Healthy Subjects

Reversal of Neuromuscular Blockade
Fujian Shengdi Pharmaceutical Co., Ltd.64 enrolled1 locationNCT07195604
Recruiting
Not Applicable

Neuromuscular Monitoring in Children (6 Months - 2 Years) With Electromyography and Acceleromyography

Neuromuscular Blockade
Matias Vested120 enrolled1 locationNCT06409260
Recruiting
Not Applicable

Deep Neuromuscular Blockade on Postoperative Pain

Neuromuscular Blockade
Seoul National University Hospital106 enrolled1 locationNCT06679569
Recruiting
Not Applicable

Incidence of Residual Neuromuscular Blockade in Fraility in OncoGynae Surgery

Gynecologic CancerSurgical ComplicationFrailty+2 more
Mahidol University622 enrolled1 locationNCT06216002
Recruiting

International Focus Group Discussion on Neuromuscular Monitoring.

AnesthesiaPerioperative/Postoperative ComplicationsNeuromuscular Blockade+2 more
Universitair Ziekenhuis Brussel16 enrolled1 locationNCT06945341
Recruiting
Not Applicable

The Clinical Effect of Sugammadex Sodium (Domestic) for Antagonizing Neuromuscular Blockade After Thoracic Surgery

Neuromuscular Blockade
The Fourth Affiliated Hospital of Zhejiang University School of Medicine80 enrolled1 locationNCT06334562
Recruiting
Phase 1Phase 2

Recovery Times of Half Dose Sugammadex and Neostigmine for Rocuronium-induced Neuromuscular Blockade

Recovery TimeNeuromuscular Blocking AgentsReversal of Neuromuscular Blockade
Universitas Padjadjaran60 enrolled1 locationNCT06794450
Recruiting
Phase 4

Ephedrine for Reducing Onset Time of Rocurinium in Elderly Patients

Neuromuscular Blockade
Matias Vested80 enrolled2 locationsNCT06681662
Recruiting
Not Applicable

Pharmacological Reversal of Neuromuscular Blockade in Critically Ill Patients

Critical IllnessNeuromuscular BlockadeNeurologic Findings
Seoul National University Hospital30 enrolled1 locationNCT05993390
Recruiting
Not Applicable

Deep Neuromuscular Block Affect the Quality of Recovery After Laparoscopic Hysterectomy

Neuromuscular Blockade
Anqing Municipal Hospital72 enrolled1 locationNCT06469866
Recruiting
Phase 4

Interaction of Volatile Anesthetics With Magnesium

Neuromuscular Blockade
Christoph Czarnetzki96 enrolled1 locationNCT05261516
Recruiting
Phase 4

Measurement of Blood Loss in Adenotonsillectomy During General Anesthesia According to the Application of Nondepolarizing Muscle Relaxants

Intraoperative BleedingAnesthesiaNeuromuscular Blockade
University Hospital of Split60 enrolled1 locationNCT06399445